Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moustafa T Gabr

Showing results (51-60 of 107) with videos related to

Pageof 11
Sort By:
Biorxiv : the Preprint Server for Biology|June 4, 2025
CHI3L1-Targeted Small Molecules as Glioblastoma Therapies: Virtual Screening-Based Discovery, Biophysical Validation, Pharmacokinetic Profiling, and Evaluation in Glioblastoma SpheroidsHossam Nada, Longfei Zhang, Baljit Kaur, et al.
European Journal of Medicinal Chemistry|May 14, 2025
First-in-class dual inhibitors of MASTL and Aurora A kinase: Discovery of selective cyclohexa[b]thiophenes with potent anticancer activitySomaya A Abdel-Rahman, Hossam Nada, Moustafa T Gabr
Biorxiv : the Preprint Server for Biology|November 24, 2025
Structure-Guided Optimization and Functional Characterization of Small Molecule Antagonists Targeting CD28 CostimulationSaurabh Upadhyay, Hossam Nada, Sungwoo Cho, et al.
RSC Medicinal Chemistry|June 7, 2021
A benzoxazole derivative as an inhibitor of anaerobic choline metabolism by human gut microbiotaMoustafa T Gabr, David Machalz, Szymon Pach, et al.
Biomed Research International|July 28, 2020
Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target CombinationsSamuele Maramai, Mohamed Benchekroun, Moustafa T Gabr, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 20, 2025
Overcoming the undruggable barrier: Structure-guided discovery of a potent small molecule CD28 antagonist with translational potentialSaurabh Upadhyay, Hossam Nada, Sungwoo Cho, et al.
ACS Medicinal Chemistry Letters|June 19, 2024
Structure-Based Rational Design of Constrained Peptides as TIM-3 InhibitorsSomaya A Abdel-Rahman, Victor Ovchinnikov, Moustafa T Gabr
RSC Advances|January 19, 2024
Lithocholic acid derivatives as potent modulators of the nuclear receptor RORγtSomaya A Abdel-Rahman, Simone Brogi, Moustafa T Gabr
RSC Medicinal Chemistry|September 21, 2023
First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulatorsSomaya A Abdel-Rahman, Katarzyna Świderek, Moustafa T Gabr
Bio-Protocol|March 2, 2026
Orthogonal Temperature-Related Intensity Change and Time-Resolved Förster Resonance Energy Transfer High-Throughput Screening Platform for the Discovery of SLIT2 BindersNelson García-Vázquez, Somaya A Abdel-Rahman, Moustafa T Gabr
Pageof 11

Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|June 4, 2025
CHI3L1-Targeted Small Molecules as Glioblastoma Therapies: Virtual Screening-Based Discovery, Biophysical Validation, Pharmacokinetic Profiling, and Evaluation in Glioblastoma SpheroidsHossam Nada, Longfei Zhang, Baljit Kaur, et al.
European Journal of Medicinal Chemistry|May 14, 2025
First-in-class dual inhibitors of MASTL and Aurora A kinase: Discovery of selective cyclohexa[b]thiophenes with potent anticancer activitySomaya A Abdel-Rahman, Hossam Nada, Moustafa T Gabr
Biorxiv : the Preprint Server for Biology|November 24, 2025
Structure-Guided Optimization and Functional Characterization of Small Molecule Antagonists Targeting CD28 CostimulationSaurabh Upadhyay, Hossam Nada, Sungwoo Cho, et al.
RSC Medicinal Chemistry|June 7, 2021
A benzoxazole derivative as an inhibitor of anaerobic choline metabolism by human gut microbiotaMoustafa T Gabr, David Machalz, Szymon Pach, et al.
Biomed Research International|July 28, 2020
Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target CombinationsSamuele Maramai, Mohamed Benchekroun, Moustafa T Gabr, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 20, 2025
Overcoming the undruggable barrier: Structure-guided discovery of a potent small molecule CD28 antagonist with translational potentialSaurabh Upadhyay, Hossam Nada, Sungwoo Cho, et al.
ACS Medicinal Chemistry Letters|June 19, 2024
Structure-Based Rational Design of Constrained Peptides as TIM-3 InhibitorsSomaya A Abdel-Rahman, Victor Ovchinnikov, Moustafa T Gabr
RSC Advances|January 19, 2024
Lithocholic acid derivatives as potent modulators of the nuclear receptor RORγtSomaya A Abdel-Rahman, Simone Brogi, Moustafa T Gabr
RSC Medicinal Chemistry|September 21, 2023
First-in-class small molecule inhibitors of ICOS/ICOSL interaction as a novel class of immunomodulatorsSomaya A Abdel-Rahman, Katarzyna Świderek, Moustafa T Gabr
Bio-Protocol|March 2, 2026
Orthogonal Temperature-Related Intensity Change and Time-Resolved Förster Resonance Energy Transfer High-Throughput Screening Platform for the Discovery of SLIT2 BindersNelson García-Vázquez, Somaya A Abdel-Rahman, Moustafa T Gabr
Pageof 11